Journal issue - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Journal issue

Chinese Journal of Oncology

Issue 10, 2023

Items 1-5 of 8

«Preious | of 2 | Next»

1

Breast cancer treatment guidelines(2022 edition)

Chinese Journal of Oncology, Volume 45, Issue 10,2023, Pages 803-833, doi:10.3760/cma.j.cn112152-20230706-00281

2

Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway

Chinese Journal of Oncology, Volume 45, Issue 10,2023, Pages 879-891, doi:10.3760/cma.j.cn112152-20201217-01075

3

Efficacy and safety of Anlotinib in the treatment of advanced sarcoma

Chinese Journal of Oncology, Volume 45, Issue 10,2023, Pages 904-910, doi:10.3760/cma.j.cn112152-20210820-00632

4

Chinese expert consensus on celiac lymphadenectomy during open/minimally invasive esophagectomy (2023 edition)

Chinese Journal of Oncology, Volume 45, Issue 10,2023, Pages 871-878, doi:10.3760/cma.j.cn112152-20230330-00136

5

A phase I study of subcutaneous envafolimab (KN035) monotherapy in Chinese patients with advanced solid tumors

Chinese Journal of Oncology, Volume 45, Issue 10,2023, Pages 898-903, doi:10.3760/cma.j.cn112152-20220530-00373

Items 1-5 of 8

«Preious | of 2 | Next»

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn